Technical Data

P4296-ML550
Clone Type
Monoclonal
Host
Mouse
Source
Mouse
Conjugate
MaxLight™550
Isotype
IgG2b
Clone Number
5H31 (36.1-104)
Grade
Affinity Purified
Applications
IC WB
Crossreactivity
Mo
Shipping Temp
Blue Ice
Storage Temp
4°C Do Not Freeze
Notes
Preservative Free
BSA Free
Mouse Anti-PML (Promyelocytic Leukemia Protein) (MaxLight 550)

MaxLight™550 is a new Yellow-Green photostable dye conjugate comparable to Alexa Fluor™546, 555, DyLight™549 , Cy3™, TRITC and offers better labeling efficiency, brighter imaging and increased immunodetection. Absorbance (550nm); Emission (575nm); Extinction Coefficient 150,000.

PML protein is a tripartite motif (TRIM)-containing nuclear protein that may function as, among other things, a transcription factor, a coactivator of nuclear receptors, a regulator of apoptosis, a mediator of interferon-induced antiviral response, and as a suppressor of growth and oncogenic transformation. PML is localized to the nucleoplasm and in distinct subnuclear structures referred to as Promyelocytic Leukemia Bodies (also known as Nuclear Domain 10). Localization of PML to Promyelocytic Leukemia Bodies requires modification of PML protein by the Small Ubiquitin Modifier (SUMO) and is required for proper formation and integrity of these subnuclear structures. At least 14 splice variants of PML ranging in molecular weight from 48-97kD (predicted) have been described in the literature. The functional significance of the various splice variants is not well understood. In patients with Acute Promyelocytic Leukemia, the PML gene is involved in at least two specific chromosomal translocations that result in the expression of chimeric proteins with the Retinoic Acid Receptor alpha. All isoforms of PML, as well as the PML-RARalpha chimeric proteins expressed in Type A and Type B APL contain an identical N-terminus but vary in the C-terminal portion of the protein.
Applications
Suitable for use in Western Blot and Immunocytochemistry. Other applications not tested.
Recommended Dilution
Western Blot: 0.5-1ug/ml of this lot detected PML in RIPA lysates from mouse embryo fibroblast (MEF1) cells. Immunocytochemistry: An independent laboratory showed positive immunostaining for PML in MEF1 cells fixed with 4% paraformaldehyde and permeabilized with 0.2% Triton X-100. Optimal dilutions to be determined by the researcher.
Storage and Stability
Store product at 4°C in the dark. DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Caution: MaxLight™550 conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Note: Applications are based on unconjugated antibody.
Immunogen
6His fusion protein corresponding to aa1-581 of mouse PML (promyelocytic leukemia protein).
Form
Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with MaxLight™550.
Purity
Purified by Protein G affinity chromatography.
Specificity
Recognizes mouse PML, Mr ~90-106kD, depending on degree of protein modification. Does not crossreact with human. MEF1 cell lysate was resolved by electrophoresis, transferred to nitrocellulose and probed with P4296. Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and a chemiluminescence detection system.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

References
1. Ferbeyre, G., et al., Genes and Dev. 14: 2015-2027, 2000. 2. Jensen, K., et al., Oncogene 20: 7223-7233, 2001. 3. Kamitani, T., et al., J. Biol. Chem. 273: 3117-3120, 1998. 4. Guo, A. et al. (2002). The function of PML in p53-dependent apoptosis. Nature Cell Biology 2:730-736. 5. Pandolfi, P. (2001). Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia. Human Molecular Genetics 10:769-775. 6. Jenson, K. et al. (2001). PML protein isoforms and the RBCC/TRIM motif. Oncogene 20:7223-7233. 7. Regand, T. and Chelabi-Alix, M. (2001). Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20:7274-7286. 8. Rugerrio, D. et al. (2000). The puzzling multiple lives of PML and its role in the genesis of cancer. Bioessays 22:827-835. 9. Mu, Z. et al. (1997). Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 18:1063-2069.
USBio References
No references available
United States Biological | 4 Technology Way | Salem, MA 01970
Phone 800-520-3011 | Fax 978-594-8052 | Website www.usbio.net